Abstract-Time-dependent changes in the blocking effect of diltiazem on nor epinephrine (NE)-induced vasoconstrictions were investigated in isolated canine pulmonary veins. Within 2-3 hr of the perfusion period, pretreatment with diltiazem did not affect the vasoconstrictor responses to NE. However, in the 8-11 hr perfused preparations, diltiazem suppressed the NE-induced vasocon striction significantly.
Abstract-Time-dependent changes in the blocking effect of diltiazem on nor epinephrine (NE)-induced vasoconstrictions were investigated in isolated canine pulmonary veins. Within 2-3 hr of the perfusion period, pretreatment with diltiazem did not affect the vasoconstrictor responses to NE. However, in the 8-11 hr perfused preparations, diltiazem suppressed the NE-induced vasocon striction significantly.
It may participate in the mechanisms for the appearance of the blocking effect in the following manner: 1) a proportion of alpha adrenoceptors which are sensitive to calcium entry are increased and/or 2) spare alpha adre noceptors are decreased time-dependently.
It has been reported that calcium entry blocking agents reduced pressor responses to selective alpha-2 adrenoceptor agonists more effectively than the responses to selective alpha-1 adrenoceptor agonists (1, 2), with some exceptions (3). By some in vitro studies evaluating calcium influx during adrenergic stimulation (4), it was corrobo rated to some extent that calcium influx into smooth muscle cells was necessary for the function of alpha-2 adrenoceptors.
On the other hand, it has been also suggested that the resistance of certain alpha-1 adre noceptor mediated pressor responses to calcium entry blocking agents is associated with the presence of a significant receptor reserve that buffers this response against inhibition by calcium entry blockers (5). Recently, we demonstrated that alpha-2 adrenoceptor mediated vasoconstrictor re sponses to xylazine were perfusion-time dependently enhanced in the isolated and perfused dog pulmonary veins (6). In the present study, we investigated time dependent changes in norepinephrine induced vasoconstriction and the blocking effect of diltiazem, bunazosin (7) or DG 5128 (8) on the NE-induced vasocon strictions using isolated and perfused dog pulmonary veins. Twenty-two mongrel dogs (7-16 kg) of either sex were anesthetized with sodium pentobarbital (30 mg/kg, i.v.). After treat ment with sodium heparin (200 units/kg, i.v.), dogs were sacrificed by rapid exsangui nation from the right common carotid artery. Upon removal from the animal, the lung was placed immediately in cold Krebs-Ringer solution. After removal of loosely adhering tissues and tying branches with fine silk threads, segments of pulmonary veins (1.6 2.2 mm in outer diameter and 1.8-2.5 cm in length) were dissected carefully from the lung. Isolated pulmonary veins were can nulated as described previously (9). The isolated, cannulated vein was placed in a bath maintained at 37°C and perfused with Krebs-Ringer bicarbonate solution by means of a circulator pump (MP-3A; Tokyo Rika kikai Co., Tokyo, Japan).
The perfusion solution was bubbled with 95% 02 and 5% C02 which maintained the solution at a pH between 7.2-7.4. In addition, propranolol (10-7M) was added to the perfusion solution to block beta-adrenoceptors. The flow rate was initially adjusted so that the perfusion pressure was between 5-10 mmHg, and then it was kept constant throughout the experiment (1.9-2.7 ml/min). In the early stage, NE (0.001-3 /cg), which was injected into the cannulated pulmonary vein, induced dose-dependent increases in perfusion pressure, and these vasocon strictor responses did not change statistically in the late stage. The threshold dose of NE for inducing a vasoconstriction was usually 0.001 ,ug, and 3 /cg of N E caused a maximal increase in perfusion pressure of 15.3±1.2 mmHg (n=22).
NE at a dose of 0.1 ug brought about a 50% contractile response of the maximum in both stages. In the early stage, 0.1 icg of NE induced a vasocon striction of 10.2±1.1 mmHg (n=12). After pretreatment with increasing doses of dil tiazem (1-100 tig), NE-induced vasocon strictor responses were not affected at this stage (Fig. 1A) . In the late stage, injections of NE (0.1 ,ug) induced vasoconstrictions (9.2±2.1 mmHg, n=12) to the same degree as in the early stage. However, at the late stage, increasing doses of diltiazem (1-100 /ig) significantly suppressed the NE-induced vasoconstriction (Fig. 1 B) . In this stage, 100 /cg of diltiazem reduced NE (0.1 ,eg) induced vasoconstrictions to 58% of the control. Summarized data are shown in Fig.  2A . 1 adrenoceptor antagonist, and DG-5128 (1 100 ,ug), a selective alpha-2 adrenoceptor antagonist, on NE-induced vasoconstrictions were examined. We demonstrated previously that these doses of bunazosin and DG-5128 provided selective blockade of alpha-1 and alpha-2 adrenoceptors, respectively, in the isolated and perfused canine pulmonary vein (6). In both stages, vasoconstrictor effects of NE (0.1 ,ug) were antagonized by bunazosin which was injected 2-3 min before NE (Fig.  2B ). In the late stage, these antagonistic effects of bunazosin on NE-induced vaso constrictions, however, were reduced sig nificantly. After pretreatment with increasing doses of DG-51 28, vasoconstrictor effects of NE were also depressed in both stages (Fig.  2C ). In contrast with bunazosin, the sup pressive effects of DG-5128 on NE-induced vasoconstrictions were slightly enhanced in the late stage, but this was not statistically significant.
It has been reported that pressor responses elicited by alpha-1 adrenoceptor agonists are resistant to antagonism by calcium entry blocking agents, whereas responses induced by alpha-2 adrenoceptor agonists are sensi tive to the inhibitory effects of calcium entry antagonists (1, 2). In this study, it was demonstrated that in the early and late stages, both alpha-1 and alpha-2 adrenoceptors mediated NE-induced vasoconstrictions in the isolated and perfused dog pulmonary vein, because NE-induced responses were inhibited by not only bunazosin but also DG-5128. However, the pretreatment with diltiazem, a calcium entry blocking agent, could not reduce vasoconstrictor responses to NE in the early stage. This result suggests that in the early stage, NE-induced alpha-1 and alpha-2 adrenoceptor mediated vaso constrictions were resistant to antagonism by diltiazem. A possible explanation for this phenomenon is that alpha-2 adrenoceptors which are less sensitive to calcium entry blocking agents exist in this preparation. It may be considered that there are two kinds of alpha-2 adrenoceptors, i.e., calcium entry sensitive and non-sensitive alpha-2 adre noceptors; and in the early stage, alpha-2 adrenoceptors might be mostly insensitive to calcium entry in the isolated and perfused canine pulmonary veins. In 1984, Ruffolo and Yaden (10) reported that the alpha-1 adre noceptor reserve was approximately 5-fold greater than the alpha-2 adrenoceptor reserve in the pithed rat, and the differential inhibitory effect of calcium entry antagonists may be related to differences in the number of spare receptors in the alpha-1 and post junctional alpha-2 adrenoceptor populations (5). From the receptor reserve hypothesis, it may be also considered that in the early stage, the isolated and perfused dog pul monary vein has enough alpha-1 and alpha 2 spare receptors to resist 100 ,ug of diltiazem.
In this study, it was demonstrated that there was no statistical difference in vaso constrictor responses elicited by NE between the two stages.
The blocking effect of diltiazem on NE-induced vasoconstriction, however, appeared only in the late stage. In the late stage, the suppressive effect of bunazosin on NE-induced vasoconstriction was significantly decreased. Although not statistically significant, the suppressive effect of DG-5128 on it was slightly enhanced. It seems that the proportion of NE-induced alpha-2 adrenoceptor-mediated vasocon striction may be slightly enhanced by the long time perfusion.
As this change is relatively small, it alone does not fully explain the time-dependent appearance of the blocking effect of diltiazem. Another possible explanation for this appearance is that the properties of alpha-2 and/or alpha-1 adrenoceptors in the isolated and perfused canine pulmonary vein might change in the case of long-time perfusion so that they become calcium influx sensitive. By the receptor reserve theory, the appearance of the blocking effect of diltiazem on NE induced vasoconstriction may be also interpreted as indicating that the number of spare alpha-2 and/or alpha-1 adrenoceptors decrease time-dependently and can not buffer NE-induced alpha adrenoceptor midiated responses against the inhibitory effects of diltiazem.
Our present results do not allow us to make conclusions about the precise mecha nisms of this perfusion-time-dependent ap pearance of the blocking effect of diltiazem on NE-induced vasoconstrictions in the isolated and perfused dog pulmonary vein. Further experiments using selective alpha-1 and alpha-2 agonists, and which can demon strate Ca" movement directly, are necessary to provide the exact mechanism.
